Maicol Mancini
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 3
-
- PI3K/AKT/mTOR signaling in cancer 4
- RNA modifications and cancer 2
- Co-authors
- Yosef Yarden (5 shared papers)Michael Sela (3 shared papers)Ruth Maron (2 shared papers)Bilha Schechter (2 shared papers)Yosef Yarden (3 shared papers)Moshit Lindzen (4 shared papers)Nadège Gaborit (3 shared papers)Sara Lavi (2 shared papers)
- Journals
- Science Signaling (4 papers)EMBO Molecular Medicine (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cancers (2 papers)Biology Open (2 papers)
- Partner nations
- FranceIsraelUnited Kingdom
In The Last Decade
Maicol Mancini
20 papers receiving 712 citations
Peers
Comparison fields: 5 of 77
- Oncology 250
- Cancer Research 97
- Molecular Biology 412
- Pulmonary and Respiratory Medicine 171
- Radiology, Nuclear Medicine and Imaging 98
Countries citing papers authored by Maicol Mancini
This map shows the geographic impact of Maicol Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maicol Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maicol Mancini more than expected).
Fields of papers citing papers by Maicol Mancini
This network shows the impact of papers produced by Maicol Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maicol Mancini. The network helps show where Maicol Mancini may publish in the future.
Co-authors
The 25 scholars most cited alongside Maicol Mancini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 147 | |
| 2 | 2015 | 77 | |
| 3 | 2015 | 54 | |
| 4 | 2018 | 50 | |
| 5 | 2017 | 48 | |
| 6 | 2018 | 46 | |
| 7 | 2019 | 43 | |
| 8 | 2015 | 42 | |
| 9 | 2013 | 39 | |
| 10 | 2015 | 38 | |
| 11 | 2020 | 37 | |
| 12 | 2015 | 33 | |
| 13 | 2015 | 30 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2025 | 2 |
About Maicol Mancini
Maicol Mancini is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Sensory Systems and Cell Biology, having authored 22 papers that have together received 723 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Research Studies (3 papers), Advanced Chemical Sensor Technologies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Microtubule and mitosis dynamics (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (250 citations), Cancer Research (97 citations), Molecular Biology (412 citations), Pulmonary and Respiratory Medicine (171 citations) and Radiology, Nuclear Medicine and Imaging (98 citations). Maicol Mancini has collaborated with scholars based in France, Israel and United Kingdom. Frequent co-authors include Yosef Yarden, Michael Sela, Ruth Maron, Bilha Schechter, Yosef Yarden, Moshit Lindzen, Nadège Gaborit, Sara Lavi, Stefan Wiemann and Ashish Noronha. Their work appears in journals such as Science Signaling, EMBO Molecular Medicine, Proceedings of the National Academy of Sciences, Cancers and Biology Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.